Remicade (infliximab) - J&J
CNTO6785 - J&J, Fontacea
Tezspire (tezepelumab-ekko) - AstraZeneca, Amgen
Nucala (mepolizumab) - GSK
astegolimab (RG 6149) - Amgen, Roche
tozorakimab (MEDI3506) - AstraZeneca
Ilaris (canakinumab) - Novartis
AMG 108 - AstraZeneca
itepekimab (SAR440340) - Sanofi, Regeneron
Fasenra (benralizumab) - AstraZeneca
Dupixent (dupilumab) - Sanofi, Regeneron
http://www.ncbi.nlm.nih.gov/pubmed/40955382
 
Luigino Calzetta; Maria Gabriella Matera; Mario Cazzola; Paola Rogliani
 
Sep 16, 2025
 
Next